Toggle light / dark theme

Get the latest international news and world events from around the world.

Log in for authorized contributors

Researchers Discover the Cell’s Secret Anti-Aging Mechanism

Activating lysosome biogenesis helps alleviate cellular senescence in progeria. Hutchinson-Gilford progeria syndrome (HGPS) is a rare genetic condition that causes rapid aging and a range of visible and internal symptoms. Individuals with HGPS often experience early skin wrinkling, reduced skin ela

Bioelectronic-integrated artificial colon eliminates need for animal testing

Researchers at the University of California, Irvine have developed a 3D human colon model integrated with bioelectronics to aid in colorectal cancer research and drug discovery. The “3D in vivo mimicking human colon” enables precision, personalized medicine and offers a more ethical, accurate and cost-effective alternative to traditional animal testing.

In a paper published recently in the journal Advanced Science, researchers in UC Irvine’s Samueli School of Engineering outline their creation of an approximately 5-by-10-millimeter replica that incorporates essential structural features of a colon, including liminal curvature, multilayered cellular organization and the spontaneous formation of cryptlike indentations.

“The three-dimensional shapes, curves and crypts in our 3D-IVM-HC model are central to maintaining more realistic cell behavior even at a scaled-down size,” said senior author Rahim Esfandyar-pour, UC Irvine assistant professor of electrical engineering and computer science.

First major trial of AI in breast cancer screening launches in the USA

A study led by Sylvester Comprehensive Cancer Center, part of University of Miami Miller School of Medicine (FL, USA) seeks to understand how AI can improve breast cancer screening. The Pragmatic Randomized Trial of Artificial Intelligence for Screening Mammography (PRISM) trial will examine hundreds of thousands of mammograms to “assess AI’s true impact”

Despite huge investments in research, breast cancer remains a leading cause of mortality in US women. Routine mammography has increased the diagnosis of early-stage cancer, but the increased incidence of false positives can lead to unnecessary testing, anxiety and higher costs.

“As the first major randomized trial of AI in breast cancer screening in the US, this study represents a pivotal step,” commented Jose Net, University of Miami Miller School of Medicine and co-principal investigator of the study. “Our goal is to rigorously and objectively assess AI’s impact, identifying who benefits and who may not.”

Discovery of brain parasite’s unique control protein offers hope for better toxoplasmosis treatments

Rajshekhar Gaji was staring at something that should not exist. Under his microscope, parasites that should have been thriving were instead dying—completely unable to survive without a protein his lab had managed to switch off.

“It was an amazing day,” said Gaji, assistant professor of parasitology at the Virginia–Maryland College of Veterinary Medicine. That moment of discovery could eventually help the 40 million Americans walking around with a microscopic parasite permanently residing in their brains.

The findings are published in the journal mSphere.

Gene therapy delivers lasting immune protection in children with rare disorder

An experimental gene therapy developed by researchers at UCLA, University College London and Great Ormond Street Hospital has restored and maintained immune system function in 59 of 62 children born with ADA-SCID, a rare and deadly genetic immune disorder.

Severe combined immunodeficiency due to adenosine deaminase deficiency, or ADA-SCID, is caused by mutations in the ADA gene, which creates an enzyme essential for immune function. For children with the condition, day-to-day activities like going to school or playing with friends can lead to dangerous, life-threatening infections. If untreated, ADA-SCID can be fatal within the first two years of life.

The current standard treatments— from a matched donor or weekly enzyme injections—come with limitations and potential long-term risks.

/* */